{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:25:55Z","timestamp":1784697955294,"version":"3.55.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>Germline mutations of <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> and <jats:italic toggle=\"yes\">BRCA2<\/jats:italic> predispose individuals to a high risk of breast and ovarian cancer, and elevated risk of other cancers, including those of the pancreas and prostate. <jats:italic toggle=\"yes\">BRCA2<\/jats:italic> mutation carriers may have increased risk of uveal melanoma (UM) and cutaneous melanoma (CM), but associations with these cancers in <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> mutation carriers have been mixed. Here, we further assessed whether UM and CM are associated with <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> or <jats:italic toggle=\"yes\">BRCA2<\/jats:italic> by assessing the presence, segregation and reported\/predicted pathogenicity of rare germline mutations (variant allele frequency &lt; 0.01) in families with multiple members affected by these cancers. Whole-genome or exome sequencing was performed on 160 CM and\/or UM families from Australia, the Netherlands, Denmark and Sweden. Between one and five cases were sequenced from each family, totalling 307 individuals. Sanger sequencing was performed to validate <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> and <jats:italic toggle=\"yes\">BRCA2<\/jats:italic> germline variants and to assess carrier status in other available family members. A nonsense and a frameshift mutation were identified in <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>, both resulting in premature truncation of the protein (the first at p.Q516 and the second at codon 91, after the introduction of seven amino acids due to a frameshift deletion). These variants co-segregated with CM in individuals who consented for testing and were present in individuals with pancreatic, prostate and breast cancer in the respective families. In addition, 33 rare missense mutations (variant allele frequency ranging from 0.00782 to 0.000001 in the aggregated ExAC data) were identified in 34 families. Examining the previously reported evidence of functional consequence of these variants revealed all had been classified as either benign or of unknown consequence. Seeking further evidence of an association between <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> variants and melanoma, we examined two whole-genome\/exome sequenced collections of sporadic CM patients (total <jats:italic toggle=\"yes\">N<\/jats:italic> = 763). We identified one individual with a deleterious <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> variant, however, this allele was lost (with the wild-type allele remaining) in the corresponding CM, indicating that defective <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> was not a driver of tumorigenesis in this instance. Although this is the first time that deleterious <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> mutations have been described in high-density CM families, we conclude that there is an insufficient burden of evidence to state that the increased familial CM or UM susceptibility is because of these variants. In addition, in conjunction with other studies, we conclude that the previously described association between <jats:italic toggle=\"yes\">BRCA2<\/jats:italic> mutations and UM susceptibility represents a rare source of increased risk.<\/jats:p>","DOI":"10.1097\/cmr.0000000000000613","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T14:33:09Z","timestamp":1567089189000},"page":"483-490","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma"],"prefix":"10.1097","volume":"29","author":[{"given":"Peter A.","family":"Johansson","sequence":"first","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Nathan","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Bourke","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Genomics, National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Symmons","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Howlie","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Patch","sequence":"additional","affiliation":[{"name":"Medical Genomics, QIMR Berghofer Medical Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazlyn","family":"Read","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Holland","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead"},{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Schmid","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead"},{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Warrier","sequence":"additional","affiliation":[{"name":"Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Glasson","sequence":"additional","affiliation":[{"name":"Queensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"H\u00f6iom","sequence":"additional","affiliation":[{"name":"Department of Oncology and Pathology, Karolinska Institutet, Stockholm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wadt","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"J\u00f6nsson","sequence":"additional","affiliation":[{"name":"Department of Oncology, Clinical Sciences, Lund University and Sk\u00e5ne University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Olsson","sequence":"additional","affiliation":[{"name":"Department of Oncology, Clinical Sciences, Lund University and Sk\u00e5ne University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ingvar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Clinical Sciences, Lund University and Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Mann","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead"},{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Genomics, National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Hayward","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia L.","family":"Pritchard","sequence":"additional","affiliation":[{"name":"Oncogenomics Group"},{"name":"Genetics and Immunology, An L\u00f2chran, University of the Highlands and Island, Inverness, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230902","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"R2-20230902","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"R3-20230902","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"R4-20230902","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"R5-20230902","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"R6-20230902","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","article-title":"Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"key":"R7-20230902","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ng.3549","article-title":"Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma","volume":"48","author":"Moore","year":"2016","journal-title":"Nat Genet"},{"key":"R8-20230902","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"key":"R9-20230902","doi-asserted-by":"crossref","first-page":"e72144","DOI":"10.1371\/journal.pone.0072144","article-title":"A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers","volume":"8","author":"Aoude","year":"2013","journal-title":"PLoS ONE"},{"key":"R10-20230902","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Wadt","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"R11-20230902","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CMR.0b013e328343eca2","article-title":"Melanoma candidate genes CDKN2A\/p16\/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition","volume":"21","author":"Abdel-Rahman","year":"2011","journal-title":"Melanoma Res"},{"key":"R12-20230902","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10689-010-9379-9","article-title":"Contribution of CDKN2A\/P16 (INK4A), P14 (ARF), CDK4 and BRCA1\/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma","volume":"9","author":"Buecher","year":"2010","journal-title":"Fam Cancer"},{"key":"R13-20230902","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"R14-20230902","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"R15-20230902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","article-title":"Melanoma genetics","volume":"53","author":"Read","year":"2016","journal-title":"J Med Genet"},{"key":"R16-20230902","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00008390-199804000-00013","article-title":"Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives","volume":"8","author":"van Hees","year":"1998","journal-title":"Melanoma Res"},{"key":"R17-20230902","first-page":"535","article-title":"Multiple neoplasms in patients with uveal melanoma","volume":"82","author":"Caminal","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R18-20230902","first-page":"1564","article-title":"Second malignant neoplasms among long-term survivors of ovarian cancer","volume":"56","author":"Travis","year":"1996","journal-title":"Cancer Res"},{"key":"R19-20230902","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ijc.1542","article-title":"Association of ocular melanoma with breast cancer but not with cutaneous melanoma: results from the Swedish Family-Cancer Database","volume":"94","author":"Hemminki","year":"2001","journal-title":"Int J Cancer"},{"key":"R20-20230902","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"R21-20230902","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"R22-20230902","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R23-20230902","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R24-20230902","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10689-010-9377-y","article-title":"BRCA1 and BRCA2 families and the risk of skin cancer","volume":"9","author":"Ginsburg","year":"2010","journal-title":"Fam Cancer"},{"key":"R25-20230902","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdh474","article-title":"Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing","volume":"15","author":"Lorenzo Bermejo","year":"2004","journal-title":"Ann Oncol"},{"key":"R26-20230902","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","article-title":"Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations","volume":"11","author":"Moran","year":"2012","journal-title":"Fam Cancer"},{"key":"R27-20230902","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"R28-20230902","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1200\/JCO.2011.37.8828","article-title":"Uveal melanoma and BRCA1\/BRCA2 genes: a relationship that needs further investigation","volume":"29","author":"Cruz","year":"2011","journal-title":"J Clin Oncol"},{"key":"R29-20230902","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"R30-20230902","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R31-20230902","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: estimates for sites other than breast and ovary","volume":"42","author":"van Asperen","year":"2005","journal-title":"J Med Genet"},{"key":"R32-20230902","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R33-20230902","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10689-007-9143-y","article-title":"BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma","volume":"6","author":"Monnerat","year":"2007","journal-title":"Fam Cancer"},{"key":"R34-20230902","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1097-0215(19990730)82:3<325::AID-IJC3>3.0.CO;2-G","article-title":"Germline brca2 sequence variants in patients with ocular melanoma","volume":"82","author":"Sinilnikova","year":"1999","journal-title":"Int J Cancer"},{"key":"R35-20230902","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ijc.10155","article-title":"Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients","volume":"98","author":"Iscovich","year":"2002","journal-title":"Int J Cancer"},{"key":"R36-20230902","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1167\/iovs.02-0026","article-title":"Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma","volume":"44","author":"Hearle","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R37-20230902","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1375\/twin.11.2.183","article-title":"The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures","volume":"11","author":"Baxter","year":"2008","journal-title":"Twin Res Hum Genet"},{"key":"R38-20230902","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jnci\/91.5.446","article-title":"CDKN2A variants in a population-based sample of Queensland families with melanoma","volume":"91","author":"Aitken","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R39-20230902","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/aje\/kwp307","article-title":"Population-based, case\u2013control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study","volume":"170","author":"Cust","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R40-20230902","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows\u2013Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R41-20230902","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R42-20230902","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"key":"R43-20230902","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"R44-20230902","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"R45-20230902","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","article-title":"Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation","volume":"22","author":"Powell","year":"2003","journal-title":"Oncogene"},{"key":"R46-20230902","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"R47-20230902","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat Rev Cancer"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T04:04:26Z","timestamp":1693627466000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000613","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}